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Abstract 
Background: Yersinia pestis, causing deadly plague, is classified as a group A bioterrorism bacterium. Some recent 
DNA-based methods were used for detection of bioterrorism agents.
Results: Y. pestis was used as a model organism to develop an immunosensor based on surface plasmon resonance 
imaging (SPRi) using monoclonal antibody against Y. pestis F1 antigen. The experimental approach included step-
by-step detection of Y. pestis membrane proteins, lysed bacteria, intact bacteria, mock-infected powder and mock-
infected clinical specimens. SPRi detected on average 106 intact Y. pestis organisms in buffer, in mock-infected powder 
and in a 1:4 mixture with HEL cells.
Conclusions: This study offers the proof-of-concept of the SPRi-based detection of a human pathogen in both envi-
ronmental and clinical specimens.
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Background
Plague is a deadly zoonosis caused by the bacterium Yers-
inia pestis [1]. It remains a public health problem in many 
tropical countries including subtropical African coun-
tries [1, 2] and it is re-emerging in North Africa [3, 4]. 
There are no longer any plague foci in Europe, though 
plague had caused devastating epidemics for two mil-
lennia [1]. Also, Y. pestis has been classified as a group 
A bioterrorism agent [5]. Currently, the detection of 
Y. pestis in environmental and clinical specimens, is 
based on the culture of Y. pestis, a process requiring at 
least 24  h and a biosafety level 3 laboratory (BSL3) [6]; 
and PCR-based detection of DNA sequences [7], whose 
specificity has recently been challenged by the observa-
tion of pla sequences, thought to be Y. pestis-specific, 
in other organisms and non-infected rodents [8]. Also, 
immunochromatography detection of the Y. pestis-spe-
cific F1 antigen [9–11] is used for research, as this diag-
nostic assay is not widely available. Recently, some new 
approaches such as high-throughput RT-PCR-coupled 
ESI–MS assay and Luminex were applied to the detec-
tion of bioterrorism agents [12, 13]. These techniques 
required principally amplified DNA and apparently 
remained time-consuming.
In this study, Y. pestis was used as a model organism to 
test whether surface plasmon resonance imaging (SPRi) 
could be used as a novel technique for the rapid detec-
tion of pathogens in environmental and clinical speci-
mens. SPRi has advantages (high-throughput, real time, 
label-free, multi-detection and sensitive) which could be 
applied to the detection of organisms, such as Y. pestis. 
Several studies of immune reactions (cells—antibodies, 
peptides—antibodies) have been conducted with this 
technique [14, 15]. Recently, this technique was used to 
detect the plant pathogenic bacterium Acidovorax ave-
nae subsp. citrulli [16]. However, until now, SPRi has not 
been used to detect human pathogenic bacteria.
In this study, we challenged the proof-of-concept that 
SPRi could be used for the rapid detection of highly path-
ogenic organisms in environmental and clinical speci-
mens, using Y. pestis as a model organism. We developed 
a step-by-step experimental approach to test membrane 
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proteins, lysed bacteria, intact bacteria (Y. pestis Orien-




CS-SPRi Biochips and CS-SPRi Slides covered by a thin 
layer of gold and functionalized NHS groups were pur-
chased from HORIBA (Palaiseau, France). The ligand 
used in this study was a mouse monoclonal anti-
body (mAb) against the F1 antigen of Y. pestis [YPF19] 
(4.3  mg/mL) purchased from GenWay Biotech, Inc. 
(Gentaur, Belgium). A mouse non-immune control 
serum was produced and purified in our laboratory 
(URMITE, Marseille, France). The protocol to collect 
serum from non-immune mice has been approved by the 
French National Ethic Committee for Animals under the 
reference number 60-12112012. Sodium acetate, ethan-
olamine and glycine were purchased from Sigma-Aldrich 
(Saint-Quentin Fallavier, France), while phosphate buff-
ered saline (PBS) was obtained from bioMérieux (La 
Balme-les-Grottes, France).
Ligand immobilisation
Ligands diluted in 10  mM sodium acetate, pH 5 at dif-
ferent concentrations (mAb: 1, 0.5, 0.25 mg/mL; control 
serum: 1 mg/mL) were automatically deposited onto the 
chip (6 spots for each ligand with a distance of 0.7 mm 
between each spot) using a 300  nm diameter ceramic 
needle controlled by the mechanical SPRi-Arrayer (HOR-
IBA, Palaiseau, France). Needle rinsing with distilled 
water for 3 s, followed by drying with compressed air for 
3 s, were automatically repeated 3 times both before and 
after each ligand was deposited. The antibody was immo-
bilised at room temperature in a humid chamber set to 
60% relative humidity. The chip was air-dried and placed 
in the chip box at 4°C until use.
Analyte preparation
Membrane proteins
Suspensions of Y. pestis strain YPA (an Orientalis biotype, 
CSUR P100) in PBS were sonicated 5 times for 1 min on 
ice at an amplitude of 30 W with Q700 Sonicator (Qson-
ica, LLC, DENTA LABO, Avignon, France). The tubes 
were centrifuged for 5 min at 4.000×g. Supernatant was 
ultra-centrifuged for 1  h at 100.000×g. The pellet con-
taining membrane proteins was suspended in 500 µL PBS 
or 500 µL 0.2% Triton X-100, 30 mM Tris HCl pH 8 and 
2 mM MgCl2 and was then left overnight at 4°C to solu-
bilize the membrane proteins. Following the same proce-
dure, Escherichia coli was used as a negative control.
Lysed bacteria
Five hundred µL of various concentrations of Y. pes-
tis YPA were broken with acid-washed glass beads in a 
screw-cap tube using a FastPrep®-24 Instrument (MP 
Biomedicals, Illkirch, France) at a speed 4.0 m/V for 40 s. 
The tube was then centrifuged for 30 s at 6.700×g and the 
supernatant was analysed with SPRi. Bartonella quin-
tana, prepared according to the same protocol, was used 
as a negative control.
Intact bacteria
Virulent Y. pestis YPA and Y. pestis Medievalis 6B4 were 
cultured on Columbia agar and 5% sheep blood (bioMé-
rieux) at 32°C, 5% CO2 for 3–5 days. E. coli and Staphylo-
coccus aureus used as negative controls were cultured in 
the same medium at 37°C. Virulent Y. pestis was handled 
in a BSL3. Bacteria were inactivated with 70% ethanol. 
The SPRi specificity test was carried out with Y. pestis 
YPA, Y. pestis Medievalis, E. coli and S. aureus. SPRi sen-
sitivity was tested with different concentrations of Y. pes-
tis YPA.
Sandwich test
A “sandwich” test (mAb/Y. pestis/mAb) was developed 
on SPRi in order to enhance the sensitivity of the SPRi 
assay. On a chip with 1  mg/mL immobilized mAb, Y. 
pestis YPA (1.2 × 101 to 1.2 × 107 CFU/mL) was tested 
within 10 min, followed by an injection of mAb of 1/500. 
The area under the curve for each injection was analysed 
using GraphPad PRISM V6 software (GraphPad Soft-
ware, Inc., USA). The first phase (bacterial injection) 
from 0 to 11.5  min, the second phase (antibody injec-
tion) from 11.5 to 22 min and the entire process from 0 to 
22 min were analysed.
Mock‑infected powder
Y. pestis YPA mixed at different concentrations (108, 106, 
104  CFU/mL) with flour powder was tested on SPRi to 
estimate whether this technique could detect the patho-
gen in environmental samples in mimicking a bioterrorist 
alert. Powder mixed with either PBS or E. coli were used 
as negative controls. The experiment was repeated three 
times.
Mock‑infected clinical specimens
Y. pestis YPA mixed with HEL cells at ratio 1:1, 1:10, 
1:100 was used as a model to evaluate the capability of 
SPRi to detect the pathogen in infected clinical speci-
mens. A suspension of non-infected HEL cells was used 
as negative control. This experiment was performed in 
triplicate.
Page 3 of 8Huynh et al. BMC Res Notes  (2015) 8:259 
SPRi experiments
The experiments were conducted using the SPRi-Plex II 
system and monitored using SPRi P5.0.2-View software 
(HORIBA, Palaiseau, France). The running buffer for the 
SPRi-Plex II system was 10  mM PBS. Initial buffer flow 
rate was 500–1,000  µL/min to fill the fluid system for 
15 min. Once the chip was inserted into the machine, the 
analysis cell was filled at a flow rate of 750–1,000 µL/min, 
followed by a flow rate of 50 µL/min and a temperature 
of 37°C was used for all experiments. After system stabi-
lization, plasmon images were acquired by software and 
system mirror and camera. The study area deposits were 
detected on the previously acquired high-contrast image 
and spot and spot family definitions were performed. The 
plasmon curve and resonance angle were determined for 
each spot. The mirror system was shifted by the reso-
nance angle and the experiments were conducted with 
this value.
The surface of the chip was saturated for 10 min with 
500  µL of 1  M ethanolamine pH 9 and regenerated for 
10 min with 500 µL of 10 mM glycine pH 1.85 to remove 
any non-covalent bindings (unfixed antibodies and etha-
nolamine). The system was calibrated by comparing the 
reflectivity of 12.5  mM PBS and of 10  mM PBS buffer. 
Control serum not targeting Y. pestis was defined as a ref-
erence surface. This was used to make subtracted curves 
of each spot family in real time to eliminate non-specific 
signals. A 400 µL-volume of each sample was loaded into 
the system (200  µL for analysis, 200  µL for the carrier 
fluid). The interaction of each sample with the surface of 
the chip was measured for 10 min. Changes in reflectivity 
were monitored in real time on the graph and on the chip 
image. After each experiment, the chip was regenerated 
with 10 mM glycine pH 1.85.
Data analyses
The data were analysed using SPRi-Analysis software 
V1.2. The reflectivity change subtracted from the nega-
tive control plus two standard deviations was considered 
as positive. The data were analysed by means of a t-test 




In the first series of SPRi experiments, we tested the 
membrane proteins of Y. pestis YPA and E. coli (nega-
tive control) solubilized in PBS and in Triton X-100. 
As expected, in all cases the membrane proteins of 
E. coli gave the same signals as the blank (Figure 1). The 
membrane proteins of Y. pestis YPA solubilized in PBS 
(0.336 mg/mL) and in Triton X-100 (0.361 mg/mL) gave 
statistically different signals to that of E. coli solubilized 
in PBS (0.174  mg/mL) and in Triton X-100 (0.168  mg/
mL) (p  <  0.05). The detection signals of Y.  pestis pro-
teins solubilized in Triton X-100 was higher than in PBS 
(p < 0.05). Indeed, SPRi was able to detect Y. pestis mem-
brane proteins extracted with PBS and even more so with 
Triton X-100.
Sensitivity with lysed and intact bacteria
SPRi experiments were conducted with decreasing con-
centrations of lysed Y. pestis and lysed B. quintana used 
as negative control according to the FastPrep protocol to 
test detection sensitivity of lysed bacteria. Figure 2 shows 
that, as expected, the negative control remained negative. 
SPRi was able to give statistically different signals up to 
6.4 × 106 CFU/mL lysed Y. pestis compared to the nega-
tive control (p < 0.05). The same experiment performed 
with intact bacteria gave the same detection threshold 
(6.4.106  CFU/mL). Figure  2 also shows that the signals 
with lysed bacteria were statistically less significant than 
intact bacteria, whatever the concentration (p < 0.05).
Specificity and effect of mAb concentration
In this step, we wanted to test the specificity of this tech-
nique. Four different kinds of intact bacteria (E. coli, S. 
aureus, Y. pestis YPA and Y. pestis 6B4) were tested with 
anti-Y. pestis mAb previously immobilized on a chip at 
1, 0.5 and 0.25 mg/mL. In Figure 3, E. coli and S. aureus 
did not show any significant interaction with anti-Y. 
pestis mAb, as expected. Y. pestis YPA and Y. pestis 6B4 
gave significantly different signals with mAb, whatever 
the mAb concentration, compared E. coli, S. aureus 
(p < 0.05). Moreover, we noted that interaction between 
mAb and Y. pestis correlated with mAb concentration. 
mAb at 1  mg/mL gave statistically significant signals 
compared to 0.5 mg/mL and 0.25 mg/mL in the test with 
the same concentration of Y. pestis (p < 0.05).
Sandwich test
In an effort to improve the sensitivity of SPRi in detection 
of bacteria, we applied a sandwich technique (mAb/Y. 
pestis/mAb). The sandwich test signals were significantly 
higher than those obtained following non-specific bind-
ing of the injection of control (PBS and monoclonal anti-
body). In Figure  4a, the analysis of the area under the 
curve showed that the sandwich test could improve the 
sensitivity of SPRi. In Figure  4b, by testing decreasing 
concentrations of bacteria (1.2 × 107 to 1.2 × 101 CFU/
mL) using the sandwich technique, SPRi was able to 
detect Y. pestis YPA up to 1.2 × 106 CFU/mL (p < 0.05).
Mock‑infected powder and clinical specimens
To evaluate the ability to detect pathogen in environmen-
tal and clinical specimens, we tested Y. pestis mixed with 
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powder and HEL cells. Figure  5 shows that mixtures of 
Y. pestis YPA at 108 and 106 CFU/mL with powder gave 
statistically significant signals compared to the negative 
controls (PBS or E. coli with powder) (p < 0.05). In Fig-
ure 6, Y. pestis YPA (106 CFU/mL) could be detected in 
a mixture with HEL cells at a cell number ratio of 1:1, 
Figure 1 Test of membrane proteins with SPRi. Membrane proteins of E. coli (negative control) and Y. pestis solubilized in PBS and in Triton X-100 
were tested. mAb concentration was 1 mg/mL. Asterisk represents a statistically significant difference with E. coli solubilized in PBS and in Triton 
X-100.
Figure 2 Comparison of the sensitivity of SPRi in detection of lysed bacteria (FastPrep) and intact bacteria. The signals with lysed bacteria were less 
statistically significant than intact bacteria, whatever the concentration. mAb concentration was 1 mg/mL. Asterisk represents a statistically signifi-
cant difference between lysed and intact bacteria.
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corresponding to a mass ratio of 1:4 (p  <  0.05). In this 
experiment, the protein concentrations of Y. pestis YPA 
and HEL were 0.61 and 2.3  mg/mL, respectively. The 
other mixtures did not give statistically significant differ-
ences in refractive index by comparison with the negative 
control (non-infected cells). Here, a mixture of 106 CFU/
mL of Y. pestis with powder or with HEL cells could be 
also detected with SPRi.
Discussion
Rapid and accurate detection of harmful organisms in 
both clinical and environmental specimens is a constant 
goal to serve medical diagnosis and protection. SPRi, 
being reported as a high-throughput method for the 
detection of molecule interactions, including antigen–
antibody interactions, held promise to help in the rapid 
detection of organisms. The results reported in the pre-
sent study were validated by numerous controls, indicat-
ing that SPRi yielded the specific detection of Y. pestis 
used as a model organism.
As SPRi-based measures incorporate no-labelled Mab 
and since all substances could affect the reflectivity index 
of the solution, it was important to distinguish specific 
interactions from non-specific ones. To eliminate non-
specific binding to antibodies immobilized on the chip, 
the antibody not targeting the bacteria could be used as 
a blank [17]. We used the non-immune purified serum 
as a reference surface and the injection of other bacteria 
as negative controls. Reference surface interactions were 
automatically subtracted and results compared with the 
negative control to identify the specific interactions.
Moreover, specificity was confirmed by the observation 
that Gram-negative (E. coli, B. quintana) and Gram-pos-
itive (S. aureus) bacteria did not give any signal with anti-
Y. pestis mAb. Moreover, signal intensity increased with 
antibody concentration, as has previously been reported 
[16]. Here, 6.4.106/mL lysed or intact bacteria alone or 
in mock-infected powder and clinical specimens could 
be detected by SPRi. SPRi was significantly less sensitive 
when lysed bacteria were used rather than intact bacte-
ria, by contrast with a previous observation involving A. 
avenae subsp. citrulli [16]. The sandwich assay, however, 
was able to 2.4.105 Y. pestis bacteria, in line with a previ-
ous study by Puttharugsa et al. [16].
Altogether, SPRi was able to detect 105 Y. pestis bacte-
ria, an inoculum in the range of that expected to cause 
deadly plague after natural or criminal exposure to 
the pathogen. Indeed, the lowest inoculum of Y. pestis 
that consistently gave a 100% mortality rate in a mouse 
model was 104  CFU [18], suggesting that an inoculum 
of bacteria found in a bioterrorism attack would be 
>104  CFU. Specimen incubation for a few hours prior 
to the SPRi assay is a promising way to further improve 
sensitivity, as previously reported for E.  coli O157:H7 
[19]. Some new approaches were applied in the detec-
tion of bioterrorism agents. These techniques were 
principally based on amplified DNA-sequence detec-
tion including high-throughput RT-PCR-coupled ESI–
MS assay and Luminex assay [12, 13]. According to 
the current state of the art, SPRi is less sensitive than 
PCR-based techniques [20] and this sensitivity remains 
to be improved. Improving SPRi sensitivity is warranted 
Figure 3 Specificity tests of SPRi with intact bacteria. Asterisk represents a statistically significant difference with E. coli and S. aureus.
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as SPRi has advantages over PCR-based techniques: 
SPRi is specific whereas it has been shown that pla, a 
long-standing target for the PCR-based detection of Y. 
pestis is in fact detectable in non-Yersinia organisms, 
including the host [8]. In particular, Y. pestis is easily 
engineered to intentionally modify PCR targets, thus 
helping the pathogen and bioterrorism agent escape 
detection. Also, SPRi is not too time-consuming, 
requiring only 40  min for a direct assay (20  min for 
infection of analyte, 20 min for negative control) and 1 h 
for a sandwich assay. A chip with many kinds of mAb 
could be used to detect different organisms. Moreover, 
this chip could be reused several times. This makes SPRi 
appropriate for rapid, cheap, multiplexed detection. 
Once sensitivity is improved, this technique would be 
perfectly suitable for sample analysis in the context of 
a bioterrorism emergency or for routine analysis in an 
epidemic area.
Figure 4 a Area under the reflectivity curve. The second phase area (injection of mAb, 12–22 min) was 4 times greater than the first phase (injec-
tion of bacteria, the conventional technique, 0–12 min), respectively. b Sandwich tests (mAb + bacteria + mAb). Decreasing concentrations of 
Y. pestis (CFU/mL) were tested by the sandwich technique, PBS + mAb was used as negative control. mAb concentration was 1 mg/mL. Asterisk 
represents a statistically significant difference with PBS + mAb.
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Conclusions
In conclusion, SPRi is a new technique for the rapid 
detection of bacteria in environmental and clinical 
specimens, as illustrated here using Y. pestis as a model 
organism. Future improvements will be directed 
towards increasing the sensitivity of the technique.
Figure 5 Test of mock-infected powder with SPRi. mAb concentration was 1 mg/mL. Asterisk represents a statistically significant difference with E. 
coli + powder.
Figure 6 Test of mock-infected clinical specimens with SPRi. mAb concentration was 1 mg/mL. Asterisk represents a statistically significant differ-
ence with HEL cells.
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